Bharat Rasayan Limited (BHARATRAS) AI Stock Analysis

• Market Cap: ₹34.95B
• Dividend Yield: 0.02%
• Average Volume (3M): 149.00
• Price to Earnings (P/E): 26.2
• Beta (1Y): 0.36
• Revenue Growth: 6.39%
• EPS Growth: -15.53%
• Country: IN
• Employees: 816
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): 16.77
• Shares Outstanding: 16,621,073
• 10 Day Avg. Volume: 116
• 30 Day Avg. Volume: 149
• PEG Ratio: 0.64
• Price to Book (P/B): 3.78
• Price to Sales (P/S): 3.64
• P/FCF Ratio: 32.32
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 65 Neutral
• Price Target: ₹2,855.00 ▲(29.70% Upside)

Bharat Rasayan's strong financial performance is the most significant factor, supported by robust revenue growth and effective cost management. Technical analysis indicates a stable trend, though bearish momentum is possible. The valuation suggests the stock may be overvalued, with a high P/E ratio and low dividend yield.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong demand for Bharat Rasayan's products and effective market penetration, supporting long-term business expansion.

Financial Stability

Low leverage risk enhances financial stability, providing Bharat Rasayan with the flexibility to invest in growth opportunities and withstand economic downturns.

Cash Flow Generation

Strong cash flow generation allows Bharat Rasayan to fund operations, invest in new projects, and return capital to shareholders, ensuring long-term sustainability.

Negative Factors

EPS Decline

A decline in EPS growth suggests potential challenges in profitability, which could impact investor confidence and the company's ability to finance future growth.

Valuation Concerns

High valuation ratios may indicate overvaluation, potentially limiting upside potential and increasing risk of price corrections, affecting investor sentiment.

Dividend Yield

A low dividend yield may deter income-focused investors, potentially impacting the stock's attractiveness and limiting its appeal in the market.

Bharat Rasayan Limited Business Overview & Revenue Model

Company Description

Bharat Rasayan Limited manufactures and sells technical grade pesticides, intermediates, and bulk formulations in India. It offers insecticides, herbicides, fungicides, and intermediates. The company also exports its products. Bharat Rasayan Limited was incorporated in 1989 and is headquartered in New Delhi, India.

How the Company Makes Money

Bharat Rasayan Limited generates revenue primarily through the sale of its agrochemical products, which are crucial for pest control and crop protection in the agricultural sector. The company's revenue model is driven by the production and distribution of a wide variety of pesticides and related chemicals that are essential for enhancing crop yields. Key revenue streams include direct sales to farmers, partnerships with agricultural distributors, and collaborations with international agrochemical companies for product development and distribution. Additionally, the company benefits from economies of scale in manufacturing, enabling it to maintain competitive pricing while maximizing profit margins. The growing demand for sustainable agricultural practices and the increasing awareness of crop protection products further contribute to its earnings.

Bharat Rasayan Limited Financial Statement Overview

Summary

Bharat Rasayan demonstrates strong financial health with impressive revenue and profit growth, low leverage, and robust cash flow generation. The company is well-positioned in the agricultural inputs industry, with efficient operations and sound financial management.

Income Statement

Bharat Rasayan has shown strong revenue growth, with a 12.3% increase from 2024 to 2025. Gross profit margin has remained robust at 33.8% in 2025. The net profit margin improved significantly to 12.0% in 2025, indicating effective cost management. Both EBIT and EBITDA margins have improved, suggesting enhanced operational efficiency.

Balance Sheet

The company maintains a healthy financial position with a low debt-to-equity ratio of 0.08 in 2025, signaling minimal leverage risk. Return on Equity is strong at 12.5%, reflecting effective use of equity. The equity ratio is impressive at 80.3%, indicating financial stability and a solid asset base.

Cash Flow

Operating cash flow has improved significantly, aligning well with net income, resulting in a healthy operating cash flow to net income ratio of 1.19. Free cash flow saw remarkable growth, indicating strong cash generation capabilities. Free cash flow to net income ratio stands at 0.97, showing effective cash management.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	12.68B	11.73B	10.45B	12.34B	12.95B	10.80B
Gross Profit	4.34B	3.96B	3.24B	3.95B	3.69B	3.30B
EBITDA	2.18B	2.01B	1.38B	2.06B	2.66B	2.45B
Net Income	1.37B	1.41B	955.10M	1.25B	1.76B	1.64B
Balance Sheet
Total Assets	0.00	14.08B	11.97B	10.74B	10.86B	9.08B
Cash, Cash Equivalents and Short-Term Investments	2.86B	2.86B	1.41B	485.96M	66.88M	1.39B
Total Debt	0.00	852.19M	804.74M	279.37M	1.74B	584.46M
Total Liabilities	-11.30B	2.78B	2.10B	1.80B	3.16B	1.81B
Stockholders Equity	11.30B	11.30B	9.88B	8.93B	7.70B	7.27B
Cash Flow
Free Cash Flow	0.00	1.32B	140.26M	1.90B	-1.21B	1.40B
Operating Cash Flow	0.00	1.68B	410.76M	2.13B	-654.55M	1.70B
Investing Cash Flow	0.00	-1.57B	-897.00M	-605.49M	511.36M	-1.53B
Financing Cash Flow	0.00	41.22M	489.57M	-1.52B	-247.85M	-397.29M

Bharat Rasayan Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2201.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BHARATRAS, the sentiment is Negative. The current price of 2201.25 is below the 20-day moving average (MA) of 2280.14, below the 50-day MA of 2471.95, and below the 200-day MA of 2532.08, indicating a bearish trend. The MACD of -101.02 indicates Positive momentum. The RSI at 28.16 is Positive, neither overbought nor oversold. The STOCH value of 14.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BHARATRAS.

Bharat Rasayan Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BHARATRAS	65 Neutral	₹34.95B	26.24	―	0.02%	6.39%	-15.53%
INSECTICID	64 Neutral	₹19.17B	12.92	―	0.71%	6.86%	15.64%
RCF	62 Neutral	₹76.00B	24.32	―	0.93%	-3.19%	59.25%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
RALLIS	56 Neutral	₹49.16B	27.93	―	0.92%	0.91%	18.12%
NFL	45 Neutral	₹41.16B	39.07	―	1.77%	-7.78%	-70.89%
NACLIND	44 Neutral	₹40.30B	-53.27	―	―	-13.44%	-127.95%

Bharat Rasayan Limited Corporate Events

Bharat Rasayan’s Credit Ratings Reaffirmed by CARE

Bharat Rasayan Limited, a company involved in the chemical industry, has received a reaffirmation of its credit ratings from CARE Ratings Limited. The long-term bank facilities have been rated CARE AA- (AA Minus), and the short-term bank facilities have been rated CARE A1+ (A One Plus). This reaffirmation indicates a stable credit outlook for the company, which could positively impact its financial operations and reassure stakeholders about its creditworthiness.

Bharat Rasayan Limited Holds EGM with Voting on Special Resolutions

Bharat Rasayan Limited held an Extraordinary General Meeting (EGM) on November 19, 2025, where the proceedings were overseen by Chairman and Managing Director Shri Sat Narain Gupta. The meeting included a quorum, and shareholders were informed about remote e-voting provisions and the option to vote in person at the EGM. The results of the voting on two special business resolutions will be announced and submitted to the stock exchange within two days of the meeting’s conclusion.

Bharat Rasayan Limited Announces Trading Window Closure and Upcoming Financial Review

Bharat Rasayan Limited has announced the closure of its trading window in compliance with SEBI regulations to prevent insider trading. The company has scheduled a board meeting on November 11, 2025, to review and approve the unaudited financial results for the second quarter and six months ending September 30, 2025. This move is part of the company’s adherence to regulatory standards and aims to maintain transparency in its financial disclosures.